Portal de Periódicos da CAPES

An evidence‐based guideline for the management of uterine fibroids

2001; Wiley; Volume: 41; Issue: 2 Linguagem: Inglês

10.1111/j.1479-828x.2001.tb01198.x

1479-828X

Cindy Farquhar, Bruce Arroll, Alec Ekeroma, Gary Fentiman, Anne Lethaby, Lee Rademaker, Helen Roberts, Lynn Sadler, Judi Strid,

Endometriosis Research and Treatment

Australian and New Zealand Journal of Obstetrics and GynaecologyVolume 41, Issue 2 p. 125-140 An evidence-based guideline for the management of uterine fibroids C Farquhar, Corresponding Author C Farquhar Associate Professor in Reproductive Medicine, Department of Obstetrics and Gynaecology, School of Medicine, University of Auckland (Convenor)University of Auckland Department of Obstetrics and Gynaecology National Women's Hospital Claude Road Epsom Auckland, New ZealandSearch for more papers by this authorB Arroll, B Arroll Associate Professor in General Practice, Department of General Practice, School of Medicine, University of AucklandSearch for more papers by this authorA Ekeroma, A Ekeroma Senior Lecturer in Obstetrics and Gynaecology, School of Medicine, University of AucklandSearch for more papers by this authorG Fentiman, G Fentiman Obstetrician and Gynaecologist, DunedinSearch for more papers by this authorA Lethaby, A Lethaby Researcher, Cochrane Menstrual Disorders and Subfertility Group, School of Medicine, University of AucklandSearch for more papers by this authorL Rademaker, L Rademaker General Practitioner, RNZCGP, HamiltonSearch for more papers by this authorH Roberts, H Roberts Senior Lecturer in Women's Health, Department of Obstetrics and Gynaecology, School of Medicine, University of Auckland, and Research Manager New Zealand Family Planning AssociationSearch for more papers by this authorL Sadler, L Sadler Epidemiologist in Women's Health, Department of Obstetrics and Gynaecology, School of Medicine, University of AucklandSearch for more papers by this authorJ Strid, J Strid Consumer Representative, Women's Health Action, AucklandSearch for more papers by this author C Farquhar, Corresponding Author C Farquhar Associate Professor in Reproductive Medicine, Department of Obstetrics and Gynaecology, School of Medicine, University of Auckland (Convenor)University of Auckland Department of Obstetrics and Gynaecology National Women's Hospital Claude Road Epsom Auckland, New ZealandSearch for more papers by this authorB Arroll, B Arroll Associate Professor in General Practice, Department of General Practice, School of Medicine, University of AucklandSearch for more papers by this authorA Ekeroma, A Ekeroma Senior Lecturer in Obstetrics and Gynaecology, School of Medicine, University of AucklandSearch for more papers by this authorG Fentiman, G Fentiman Obstetrician and Gynaecologist, DunedinSearch for more papers by this authorA Lethaby, A Lethaby Researcher, Cochrane Menstrual Disorders and Subfertility Group, School of Medicine, University of AucklandSearch for more papers by this authorL Rademaker, L Rademaker General Practitioner, RNZCGP, HamiltonSearch for more papers by this authorH Roberts, H Roberts Senior Lecturer in Women's Health, Department of Obstetrics and Gynaecology, School of Medicine, University of Auckland, and Research Manager New Zealand Family Planning AssociationSearch for more papers by this authorL Sadler, L Sadler Epidemiologist in Women's Health, Department of Obstetrics and Gynaecology, School of Medicine, University of AucklandSearch for more papers by this authorJ Strid, J Strid Consumer Representative, Women's Health Action, AucklandSearch for more papers by this author First published: 13 February 2008 https://doi.org/10.1111/j.1479-828X.2001.tb01198.xCitations: 24AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Grant JM, Hussein IY. An audit of abdominal hysterectomy over a decade in a district hospital. Br J Obstet Gynaecol 1984; 91: 73–77. 2 Clarke A, Black N, Rowe P, Mott S., Howie K. Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study. Br J Obstet Gynaecol 1995; 102: 611–620. 3 Farquhar CM, Sadler L, Harvey S et al. A longitudinal case control study of premenopausal women undergoing hysterectomy. 2001 (submitted for publication). 4 Paul C, Skegg DC, SmeUers J, Spears GF. Contraceptive practice in New Zealand. N Z Med J 1988; 101: 809–813. 5 Lethaby A, Vollenhoven B, Sowter M. Pre-operative gonadotropin-releasing hormone analogue before hysterectomy or myomectomy for uterine fibroids (Cochrane Review). In: The Cochrane Library, Issue 2, 1999. Oxford : Update Software. 6 Vollenhoven B. Introduction: the epidemiology of uterine leiomyomas. Baillieres Clin Obstet Gynaecol 1998; 12: 169–176. 7 Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990; 94: 435–438. 8 Bronz L, Suter T, Rusca T. The value of transvaginal sonography with and without saline instillation in the diagnosis of uterine pathology in pre and post menopausal women with abnormal bleeding or suspect sonographic findings. Ultrasound Obstet Gynecol 1997; 9: 53–58. 9 Dijkhuizen FP, Broimann HA, Potters AE, Bongers MY, Heinz AP. The accuracy of transvaginal ultrasonography in the diagnosis of endometrial abnormalities. Obstet Gynecol 1996; 87: 345–349. 10 Fedele L, Bianchi S, Dorta M, Brioschi D, Zanotti F, Vercellini P. Transvaginal ultrasonography versus hysteroscopy in the diagnosis of uterine submucous myomas. Obstet Gynecol 1991; 77: 745–748. 11 Towbin NA, Gviazda IM, March CM. Office hysteroscopy versus transvaginal ultrasonography in the evaluation of women with excessive uterine bleeding. Am J Obstet Gynecol 1996; 174: 1678–1682. 12 Vercellini P, Cortesi I, Oldani S, Moschetta M, De Giorgi O, Crosignani PG. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod 1997; 12: 1768–1771. 13 Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology and management. Fertil Steril 1981; 36: 433–445. 14 Cramer DW. Epidemiology of myomas. Semin Reprod Endocrinol 1992; 10: 320–324. 15 Cooper JM, Houck RM, Rigberg HJ. The incidence of intrauterine abnormalities found at hysteroscopy in women undergoing elective hysteroscopic sterilization. J Reprod Med 1983; 28: 659–661. 16 Ross RK, Pyke MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptive. BMJ 1986; 293: 359–362. 17 Agency for Health Care Policy and Research Healthcare cost and utilisation project database. AHCPR Pub No 994)046 September 1999. 18 Clayton RN, Ogden V, Hodgkinson J et al. How common are polycystic ovaries in normal women and what is their significance for the fertility of the population Clin Endocrinol (Oxf) 1992; 37: 127–134. 19 Farquhar CM, Birdsall M, Manning P, Mitchell JM. Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries on ultrasound scanning in a population of randomly selected women. Ultrasound Obstet Gynecol 1994; 4: 54–59. 20 Poison DW, Adams J, Wadsworth J, Franks S. Polycystic ovaries - a common finding in normal women. Lancet 1988; 17: 870–872. 21 Lumbiganon P, Rugpao S, Phandhu-fung S., Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol 1996; 103: 909–914. 22 Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynecol Obstet 1995; 51: 127–131. 23 Meilahn EN, Matthews KA, Egeland G., Kelsey SF. Characteristics of women with hysterectomy. Maturitas 1989; 11: 319–329. 24 Shikora SA, Niloff JM, Bistrian BR, Forse RA., Blackburn GL. Relationship between obesity and uterine leiomyomata. Nutrition 1991; 7: 251–255. 25 Parazzini F, La Vecchia C, Negri E et al. Epidemiological characteristics of women with uterine fibroids: a case-control study. Obstet Gynecol 1996; 72: 853–857. 26 Samadi AR., Lee NC., Flanders WD., Boring JR., Parris EB. Risk fac tors for self-reported uterine fibroids: a case-control study. Am J Public Health 1996; 86: 858–862. 27 WHO Scientific Group. Oral Contraceptives and Neoplasia. WHO Technical Report Series No 817. Geneva : World Health Organisation 1992: 1–46. 28 Carlson KJ., Miller BA., Fowler FJ. The Maine Women's Health Study: II. Outcomes of non surgical management of leiomyomas. abnormal bleeding and chronic pelvic pain Obstet Gynecol 1994; 83: 566–572. 29 Candiani GB, Vercellini P, Fedele L., Arcalnl I., Bianchi S., Candiani M. Use of gosereltn depot, a gonadotropin releasing hor mone agonist, for the treatment of menorrhagia and severe anaemia in women with leiomyomata uteri. Acta Obstet Gynecol Scand 1990; 69: 413–415. 30 Aharon! A., Reiter A., Golan D., Paltieiy Y., Sharf M. Patterns of growth of uterine leiomyomas during pregnancy. A prospective longitudinal study. Br J Obstet Gynaecol 1988: 95: 510–513. 31 Lev-Toaff AS, Coleman BG., Arger PH., Mintz MC., Arenson RL., Toaff ME. Leiomyomas in pregnancy: sonographic study. Radiology 1987: 164: 375–380. 32 Muram D, Gillieson M., Walters JH. Myomas of the uterus In preg nancy: ultrasonographic follow up. Am J Obstet Gynecol 1980; 138: 16–19. 33 Strobelt N, Ghidini A, Cavallone M, Pensabene I., Ceruti P., Vergani P. Natural history of uterine leiomyomas In pregnancy. J Ultrasound Med 1994: 12: 399–401. 34 Sadler L. Personal communication 1999. 35 American College of Obstetricians and Gynaecologists. Uterine leiomyomata. Technical Bulletin No 192. May 1994. 36 Lumsden MA, Wallace EM. Clinical presentation of uterine fibroids. Baillieres Clin Obstet Gynaecol 1998: 12: 177–195. 37 Rybo G, Leman J., Tibbin R. Epidemiology of menstrual blood loss. In: Baird DT. Michiea (Eds). Mechanisms of Menstrual Bleeding. New York : Raven Press: 1985: 181–193. 38 Fraser IS, McCarron G, Markham R, Resta T, Watts A. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder. Obstet Gynecol 1966; 68: 630–633. 39 Luoto R, Kaprio J, Keskimaki I, Pohjanlahti JP, Rutanen EM. Incidence, causes and surgical methods for hysterectomy in Finland, 1987–1989. Int J Epid 1994; 23: 348–358. 40 Vercellini P, Bocciolone L, Rognoni MT, Bolis G. Fibroids and infertility. In: RW Shaw (Ed). Uterine Fibroids: time for review. Carrtforth Lancr : Parthenon; 1992: 47–56. 41 Eldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S., Wood C. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril 1998; 70: 687–691. 42 Farhi J, Ashkenazi J, Feldberg D, Dicker D, Oriveto R, Ben Rafael Z. Effect of uterine leiomyomata on the results of in-vitro fertilization treatment. Hum Reprod 1995; 10: 2576–2578. 43 Narayan R., Rajat, Goswamy K. Treatment of submucous fibroids and outcome of assisted conception. J Am Assoc Gynecol Uparosc 1994; 1: 307–311. 44 Shaw RW, Trabant H and The Fibroid Study Group. Placebo controlled comparison of the effectiveness of buserelin-depot formulation in the preoperative management of women with uterine fibroids [Abstract]. 6th Annual Meeting of the International Society for Gynecologic Endoscopy, Singapore, 16–19 April 1997. 45 Exacoustos C, Rosati P. Ultrasound diagnosis of uterine myomas and complications In pregnancy. Obstet Gynecol 1993; 82: 97–101. 46 DL Sackett, RB Haynes, P Tugwell eds. Clinical Epidemiology: a basic science for clinical medicine. Boston : Little, Brown; 1991: 233–234. 47 Widrich T, Bradley LD, Mitchinson AR, Collins RL. Comparison of saline infusion sonography with office hysteroscopy for the evaluation of the endometrium. Am J Obstet Gynecol 1996; 174: 1327–1334. 48 Fedele L, Bianchi S, Dorta M, Zanotti F, Brioschi D, Carinelli S. Transvaginal ultrasonography in the differential diagnosis of adenomyoma versus leiomyoma. Am J Obstet Gynecol 1992; 167: 603–606. 49 Leibman AJ, Kruse B, McSweeney MB. Transvaginal sonography: comparison with transabdominal sonography in the diagnosis of pelvic masses. Am J Roentgenol 1968; 151: 89–92. 50 Cicinelli E, Romano F, Anastasio PS, Blasi N, Parisi C, Galantino P. Transabdominal sonohysterograpny, transvaginal sonography and hysteroscopy in the evaluation of submucous myomas. Obstet Gynecol 1995; 85: 42–47. 51 Bernard JP, Lecuru F, Darles C, Robin F, De Bievre P, Taureile R. Saline contrast sonohysterograpny as first line investigation for women with uterine bleeding. Ultrasound Obstet Gynecol 1997; 10: 121–125. 52 Fleischer AC, Vasquez JM, Cullinan JA, Eisenberg E. Sonohysterography combined with sonosalpingography: correlation with endoscopic findings in infertility patients. J Ultrasound Med 1997; 16: 381–384. 53 Gaucherand P, Piacenza JM, Salle B, Rudigoz RC. Sonohysterography of the uterine cavity: preliminary investigation. J Clin Ultrasound 1995; 23: 339–348. 54 Schwarzler P, Concin H, Bosch H et al. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology. Ultrasound Obstet Gynecol 1998; 11: 337–342. 55 De Vore GR, Schwartz PE, Morris J. Hysterography: a 5 year follow up in women with endometrial carcinoma. Obstet Gynecol 1982; 60: 369–372. 56 Cooper MJ, Broadbent JA, Molnar BG, Richardson R, Magos AL. A series of 1000 consecutive out-patient diagnostic hystero-scopies. J Obstet Gynaecol 1995; 21: 503–507. 57 Gillespie A, Nichols A. The value of hysteroscopy. Aust N Z J Obstet Gynaecol 1994; 94: 85–87. 58 Nagele F, Bournas N, O'Connor H, Broadbent M, Richardson R, Magos A. Comparison of carbon dioxide and normal saline for uterine distension in outpatient hysteroscopy. Fertil Steril 1996; 65: 305–309. 59 Scoutt LM, McCarthy SM. Applications of magnetic resonance imaging. Top Magn Reson Imaging 1990; 2: 37–49. 60 Hurley V. Imaging techniques for fibroid detection. Baillières Clin Obstet Gynaecol 1998; 12: 213–224. 61 Smith FW, Cherryman GR, Bayliss AP et al. A comparative study of the accuracy of ultrasound. X-ray CT and low field MRI in the demonstration of cervical and uterine malignancy. Magn Reson Imaging 1989; 7: 677–679. 62 Mayer DP, Shipilov V. Ultrasound and magnetic resonance imagine of uterine fibroids. Obstet Gynecol Clin North Am 1995; 22: 667–725. 63 Ascher SM, Arnold LL, Part RH et al Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology 1994; 190: 803–806. 64 Ayida G, Chamberlain P, Barlow D, Koninckx P, Golding S, Kennedy S. Is routine diagnostic laparoscopy for infertility still justified? A pilot study assessing the use of hysterosalpingo-con-trast sonography and magnetic resonance imaging. Hum Reprod 1997; 12: 1436–1439. 65 Dudiak CM, Turner DA, Patel SK, Archie JT, Silver B, Norusis M. Uterine leiomyomas in the Infertile woman: preoperative localization with MR imaging versus US and hysterosalpingography. Radiology 1988; 167: 627–630. 66 Hricak H. MRI of the female pelvis. Am J Roentgenol 1985; 146: 1115–1122. 67 Hricak H, Tscholakoff D, Heinrichs L et al. Uterine leiomyomas: correlation of MR, histopathologic findings and symptoms. Radiology 1985; 158: 385–391. 68 Weinreb JC, Lowe TW, Santos-Ramos R, Cunningham FG., Parkey R. Magnetic resonance imaging in obstetric diagnosis. Radiology 1965; 154: 157–161. 69 Togashi K, Ozasa H, Konishi I et al. Enlarged uterus differentiation between adenomyosis and leiomyoma with MR imaging. Radiology 1989; 171: 531–534. 70 Soules MR, McCarty KS. Leiomyomas: steroid receptor content Variation within normal menstrual cycles. Am J Obstet Gynecol 1982; 143: 6–11. 71 Freidman AJ, Thomas PP. Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas Obstet Gynecol 1995; 85: 631–635. 72 Pitkin RM. Retraction of Freidman and Thomas71 published in Obstet Gynecol 1995; 86: 728. 73 Murphy AA, Kettel LM, Morales AJ, Roberts VJ, Yen SS. Regression of uterine leiomyomata in response to the ant iprogesterone RU 486. J Clin Endocrinol Metab 1993; 76: 513–517. 74 DeCherney AH, Maheux R, Polan ML. A medical treatment for myomata uteri Fertil Steril 1983; 39: 429–430. 75 Ueki M, Okamoto Y, Tsurunaga T, Seiki Y, Ueda M, Sugimoto O. Endocrinological and histological changes after treatment of uterine leiomyomas with danazol or buserelin. J Obstet Gynecol 1995; 21: 1–7. 76 De Leo V, Morgante G, Lanzetta D, D'Antona D, Bertieri RS. Danazol administration after gonadotropin-releasing hormone analogue reduces rebound of uterine myomas. Hum Reprod 1997; 12: 357–360. 77 Coutmho EM, Goncalves MT. Long-term treatment of leiomyomas with gestrinone. Fertil Steril 1989; 51: 939–946. 78 Makarainen L, Ylikorkala O. Primary and myoma-associated menorrhagia: role of prostaglandins and effects of ibuprofen. Br J Obstet Gynaecol 1986; 93: 974–978. 79 Ylikorkala O, Pekonen F. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia. Obstet Gynecol 1986; 68: 10–12. 80 Friedman AJ, Barbieri RL, Benacerraf BR, Schiff I. Treatment of leiomyomata with intranasal or subcutaneous leuprolide, a gonadotropin-releasing hormone agonist. Fertil Steril 1987; 48: 560–564. 81 Lumsden MA, West CP, Baird DT. Goserelin therapy before surgery for uterine fibroids. Lancet 1987; 1: 36–37. 82 Friedman AJ, Daly M, Juneau-Norcross MJ, Rein MS. Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertil Steril 1992; 58: 413–415. 83 Langer R, Golan A, Newman M, Schnieder D, Bukovsky I, Caspi E. The effect of large uterine fibroids on urinary bladder function and symptoms. Am J Obstet Gynecol 1990; 163: 1139–1141. 84 Matta WH, Shaw RW, Nye M. Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. Br J Obstet Gynecol 1989; 96: 200–206. 85 West CP, Lumsden MA, Hillier H, Sweeting V, Baird DT. Potential role for medroxyprogesterone acetate as adjunct to Goserelin (Zoladex) in the medical management of uterine fibroids. Hum Reprod 1992; 7: 328–332. 86 Friedman AJ., Daly M, Juneau-Norcross M, Gleason R, Rein MS, Le Boff M. Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years. Hum Reprod 1994; 9: 1618–1625. 87 Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril 1994; 61: 70–77. 88 Singer A, Ikomi A. Successful treatment of uterine fibroids using an intrauterine progesterone device [Abstract]. XIV FIGO Congress, Montreal, Canada, 1994. 89 Giudice LC, Irwin JC, Dsupin BA. Insulin-like growth factor (IGF), IGF binding protein (IGFBP) and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata. Hum Reprod 1993; 8: 1796–1806. 90 Pekonen F, Nyman T, Lahteenmaki P., Haukkamma M, Rautanen EM. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. J Clin Endocrinol Metab 1992; 75: 660–664. 91 Sener AB, Seckin NC, Ozman S, Gokmen O, Dogu N, Ekici E. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women. Fertil Steril 1996; 65: 354–357. 92 Gregoriou O, Vitoratos N, Papadias C, Konidaris S, Costomenos D, Chryssikopolos A. Effect of tibolone on post-menopausal women with myomas. Maturitas 1997; 27: 187–191. 93 Stovall TG, Summitt RL, Washburn SA, Ling FW. Gonadotropin-releasing hormone agonist use before hysterectomy. Am J Obstet Gynecol 1994; 170: 1744–1751. 94 Brill AI. What is the role of hysteroscopy in the management of abnormal uterine bleeding Clin Obstet Gynecol 1995; 38: 319–345. 95 Cravello L, D'Ercole C, Roge P, Boubli L, Blanc B. Hysteroscopic management of menstrual disorders: a review of 395 patients. Eur J Obstet Gynecol Reprod Biol 1996; 67: 163–167. 96 Derman SG, Rehnstrom J, Neuwirth RS. The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas. Obstet Gynecol 1991; 77: 591–594. 97 Wamsteker K, Emanuel MH, De Kruif JH. Transcervical hysteroscopic resection of submucous fibroids for abnormal uterine bleeding: results regarding the degree of intramural extension. Obstet Gynecol 1993; 82: 736–740. 98 Hart R, Molnar BG, Magos A. Long term follow up of hysteroscopic myomectomy assessed by survival analysis. Br J Obstet Gynaecol 1999; 106: 700–705. 99 Broadbent JA, Magos AL. Menstrual blood loss after hysteroscopic myomectomy. Gynaecol Endoscopy 1995; 4: 41–44. 100 Katz VL, Dorters DJ, Droegemueller W. Complications of uterine leiomyomas in pregnancy. Obstet Gynecol 1989; 73: 593–596. 101 RF Mattingley, JD. Thompson eds. Te Linde's Operative Gynaecology, 5th ed. Philadelphia : JB Lippinoctt; 1995. 102 Candiani GB, Fedele L, Parazzini F, Villa L. Risk of recurrence after myomectomy. Br J Obstet Gynaecol 1991; 98: 385–389. 103 Gomel V. From microsurgery to laparoscopic surgery: a progress. Fertil Steril 1995; 63: 464–468. 104 Hasson HM, Rotman C, Rana N, Sistos F., Drnowski WP. Laparoscopic myomectomy. Obstet Gynecol 1992: 80: 884–888. 105 Darai E, Dechaud H, Benifla JL, Renolleau C, Panel P, Madelanat P. Fertility after laparoscopic myomectomy: preliminary results. Hum Reprod 1997; 12: 1931–1934. 106 Dubuisson JB., Chapron C, Chavet X, Gregorakis SS. Fertility after laparoscopic myomectomy of large intramural myomas: preliminary results. Hum Reprod 1996; 11: 518–522. 107 Mais V, Ajossa S, Guerriero S, Mascia M, Solla E, Melis GB. Laparoscopic versus abdominal myomectomy: a prospective randomised trial to evaluate benefits in early outcome. Am J Obstet Gynecol 1996; 174: 654–658. 108 Friedmann W, Maier RF, Luitkus A, Schafer AP, Dudenhausen JW. Uterine rupture after laparoscopic myomectomy. Acta Obstet Gynecol Scand 1996; 75: 683–684. 109 Harris WJ. Uterine dehiscence following laparoscopic myomectomy. Obstet Gynecol 1992; 80: 545–546. 110 Farquhar C, Vandekerckhove P., Watson A, Vail A., Wiseman D. Interventions for preventing adhesions after surgery for subfer-tility: Barrier agents (Cochrane Review). In: The Cochrane Library, Issue 4, 1999. Oxford : Update Software. 111 Watson A, Vandekerckhove P, Lilford R. Interventions for preventing adhesions after surgery for subfertility: Liquid and fluid agents (Cochrane Review). In: The Cochrane Library, Issue 4, 1999. Oxford : Update Software. 112 Fletcher H, Frederick J, Hardie M, Simeon D. A randomized comparison of vasopressin and tourniquet as hemostatic agents during myomectomy. Obstet Gynecol 1996; 87: 1014–1018. 113 Frederick J, Fletcher H, Simeon D et al. Intramyometrial vasopressin as a haemostatic agent during myomectomy. Br J Obstet Gynaecol 1994; 101: 435–437. 114 Ginsburg ES, Benson CB, Garfield JM, Gleason RE, Friedman AJ. The effect of operative technique and uterine size on blood loss during myomectomy: a prospective randomised study. Fertil Steril 1993: 60: 956–962. 115 Chapman R. New therapeutic technique for treatment of uterine leiomyomas using laser-induced interstitial thermotherapy (LITT) by a minimally invasive method. Lasers Surg Med 1998; 22: 171–178. 116 Zreik TG, Rutherford TJ, Palter SF et al. Cryomyolysis, a new procedure for the conservative treatment of uterine fibroids. J Am Assoc Gynecol Laparosc 1998; 5: 33–38. 117 Phillips DR, Milim SJ, Nathason HG., Haselkorn JS. Experience with laparoscopic leiomyoma coagulation and concomitant operative hysteroscopy. J Am Assoc Gynecol Laparosc 1997; 4: 425–433. 118 Vilos GA, Daly LJ, Tse BM. Pregnancy outcome after laparoscopic electromyolysis. J Am Assoc Gynecol Laparosc 1998; 5: 289–292. 119 Sutton C, Personal communication 1998. 120 Gambone JC, Reiter RC, Lench JB. Short term outcome of incidental hysterectomy at the time of adnexectomy for benign disease. J Women's Health 1992; 1: 197–200. 121 Reiter RC, Wagner PL, Gamborne JC. Routine hysterectomy for large asymptomatic uterine leiomyomata: a reappraisal. Obstet Gynecol 1992; 79: 481–484. 122 Leibsohn S, D'Ablaing G., Mishell DR, Schlaerth JB. Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas Am J Obstet Gynecol 1990: 162: 968–974. 123 Ravina JH., Bouret JM., Ciraru-Vigneron N et al. [Recourse to particular arterial embolization in the treatment of some uterine leiomyoma] [French]. Bull Acad Natl Med 1997: 181: 233–243. 124 Bradley EA., Reidy JF., Forman RG., Jarosz J., Braude PR. Transcatheter uterine artery embolisation to treat large uterine fibroids. Br J Obstet Gynaecol 1998; 105: 235–240. 125 Goodwin SC., Vedantham S., McLucas B., Forno AK., Perrella R. Preliminary experience with uterine artery embolization for uterine fibroids. J Vase interv Radiol 1997: 8: 517–526. 126 Hutchins FL, Worthlngton-Kirsch RL. Initial experience with uterine artery embolization for the management of symptomatic uterine fibroids. J Am Assoc Gynecol Laparosc 1997; 4: 27. 127 Ravina JH, Herbreteau D., Clraru Vigncron N et al Arterial embolisation to treat uterine myomata Lancet 1995; 346: 671–672. 128 Worthington-Kirsch RL., Popky GL., Hutchins FL. Uterine arterial embolization for the management of leiomyomas, quality of -life assessment and clinical response. Radiology 1998: 208: 625–629. 129 Broder M. Personal communication 1999. 130 Petrucco O. Personal communication 1999. 131 Aydeniz B., Wallwiener D., Kocer C et al [Significance of myoma induced complications In pregnancy. A comparative analysis of pregnancy course with and without myoma involvement! (German). Z Geburtshilfe Neonatol 1998; 202: 154–158. 132 Monga AK, Woodhouse CR., Stanton SL. Pregnancy and fibroids causing simultaneous urinary retention and ureteric obstruc tion. Br J Urology 1996; 77: 606–607. 133 Bolaji II., Rafla NM., Mylotte MJ. Classical caesarean section through the posterior uterine wall. Ir J Med Sci 1992; 161: 46–47. 134 Fenwick DK., Divers MJ. Medical pregnancy termination in the presence of a massive uterine fibroid. Br J Clin Pract 1995: 49: 323–323. 135 Boni RA., Hebisch G., Huch A., Stallmach T., Krestin GP. Multiple necrotic uterine leiomyomas causing severe puerperal fever: ultrasound. CT, MR. and histological findings. J Comput Assist Tomogr 1994; 18: 828–831. Citing Literature Volume41, Issue2May 2001Pages 125-140 ReferencesRelatedInformation